NasdaqGS - Delayed Quote USD

Tarsus Pharmaceuticals, Inc. (TARS)

40.89
-0.06
(-0.15%)
At close: June 13 at 4:00:00 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
376,991
265,491
227,863
178,907
Total Liabilities Net Minority Interest
152,457
68,503
34,963
12,177
Total Equity Gross Minority Interest
224,534
196,988
192,900
166,730
Total Capitalization
296,379
226,807
212,334
166,730
Common Stock Equity
224,534
196,988
192,900
166,730
Capital Lease Obligations
608
398
721
1,891
Net Tangible Assets
216,208
193,121
192,900
166,730
Working Capital
276,093
219,195
209,946
164,474
Invested Capital
296,379
226,807
212,334
166,730
Tangible Book Value
216,208
193,121
192,900
166,730
Total Debt
72,453
30,217
20,155
1,891
Share Issued
38,349.83
34,211.19
26,727.46
20,726.58
Ordinary Shares Number
38,349.83
34,211.19
26,727.46
20,698.74
Treasury Shares Number
--
--
--
27.84
12/31/2021 - 10/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EWTX Edgewise Therapeutics, Inc.
15.29
-0.84%
 
CRNX Crinetics Pharmaceuticals, Inc.
31.77
-1.24%
 
SRRK Scholar Rock Holding Corporation
32.45
-2.61%
 
KRYS Krystal Biotech, Inc.
137.07
-2.32%
 
SNDX Syndax Pharmaceuticals, Inc.
10.25
-3.94%
 
IDYA IDEAYA Biosciences, Inc.
22.18
-0.45%
 
KALV KalVista Pharmaceuticals, Inc.
12.96
-0.99%
 
MLTX MoonLake Immunotherapeutics
44.21
+0.43%
 
SYRE Spyre Therapeutics, Inc.
17.29
-2.37%
 
AKRO Akero Therapeutics, Inc.
55.62
+3.85%